RSRui Shi

Rui Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rui Shi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Pang

    Department of Clinical Laboratory, Characteristic Medical Center of Chinese People’s Armed Police Force

    2 shared publications
  • Buhe Bao

    Department of Clinical Laboratory, Characteristic Medical Center of Chinese People’s Armed Police Force

    1 shared publication
  • Chao Liu

    Department of Prevention and Therapy of Cardiovascular Diseases in Alpine Environment of Plateau, Characteristic Medical Center of PAP

    1 shared publication
  • Fang Hao

    Department of Prevention and Therapy of Cardiovascular Diseases in Alpine Environment of Plateau, Characteristic Medical Center of PAP

    1 shared publication
  • Guo-Hong Yang

    Department of Prevention and Therapy of Cardiovascular Diseases in Alpine Environment of Plateau, Characteristic Medical Center of PAP

    1 shared publication
  • Hui-Xin Li

    Tianjin Medical University

    1 shared publication

Latest Publications

  • Open Access

    Transcriptomic landscape of human circular RNAs: unveiling molecular mechanisms in high-altitude adaptation

    by Buhe Bao, Mingxuan Yu, Wei Pang, Ruilin Wang, Wenbin Dong, Ying Bai, Rui Shi, Renjie Wang

    High altitude (HA) is associated with environmental stress and low oxygen levels, and HA adaptation varies among populations. This study aimed to explore HA adaptation-related circular RNAs (circRNAs) and their transcriptomic profiles. We performed high-throughput analysis on male individuals from three populations at different altitudes and identified gene copy number variations (CNVs) and numerous differentially expressed circRNAs (DEcircRNAs) via pairwise comparisons. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses showed that the parent genes of DEcircRNAs were enriched in biological regulation and the hypoxia-inducible factor-1 (HIF-1) signaling pathway. Five key DEcircRNAs (hsa_circ_0044526, hsa_circ_0022498, hsa_circ_0044534, hsa_circ_0044520, and hsa_circ_0026102) interacting with RBPs (argonaute 2 protein (AGO2) and eukaryotic translation initiation factor 4A3 (EIF4A3)) were identified. Their expression increased with altitude, with the highest expression observed at 3,000 m). Overexpression of HIF-1 was positively correlated with the upregulated expression of the five circRNAs in human endothelial cells, offering preliminary correlative evidence for investigating hypoxia-associated transcriptional links underlying high-altitude adaptation. Collectively, these DEcircRNAs may contribute to HIF-1-mediated HA adaptive metabolism.

  • Open Access

    Identification and functional analysis of differential miRNAs in young and middle-aged adults with essential hypertension: exploring potential biomarkers and therapeutic targets

    by Xiu-Long Niu, Xiao-Jing Wang, Xin Zhang, Wei Pang, Qiong Guo, Tao Wang, Yu-Tian Liang, Chao Liu, Fang Hao, Guo-Hong Yang, et al.

    Background: Essential hypertension (EH) in young and middle-aged adults is a major risk factor for cardiovascular morbidity, yet the detailed molecular mechanisms underlying this condition have not been fully understood. MicroRNAs (miRNAs) have emerged as critical regulators of gene expression and have been increasingly associated with hypertension pathogenesis. Methods: Initially, high-throughput sequencing was employed to identify miRNAs with differential expression profiles in plasma collected from six EH patients compared with six matched healthy individuals. These candidate miRNAs were then confirmed through quantitative real-time PCR (qRT-PCR). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted to elucidate the potential biological roles of these miRNAs. Mendelian randomization (MR) was subsequently applied to investigate causal associations between EH and proteins targeted by the identified miRNAs. Results: Differential expression analysis revealed 14 upregulated miRNAs and 1 downregulated miRNA in the EH group. Following this, miRNAs were enriched through MiEAA, resulting in the selection of one downregulated miRNA and four upregulated miRNAs, which were subsequently validated by qRT-PCR. KEGG pathway analysis showed that genes regulated by upregulated miRNAs were significantly enriched in pathways related to hypoxia (HIF-1 signaling pathway), inflammation (MAPK and JAK-STAT signaling pathways), vascular remodeling (Focal adhesion and TGF-beta signaling pathways), and apoptosis (p53 signaling pathway). MR analysis identified GPCPD1, regulated by hsa-miR-10b-5p, as a significant risk factor for EH (OR = 1.04, 95% CI: 1.00–1.09, p = 2.32 × 10 −3 ). Moreover, proteins regulated by upregulated miRNAs, such as CDKN1B, PDGFRA, and THBS2, were found to be protective factors against EH. Conclusion: GPCPD1, regulated by hsa-miR-10b-5p, is a potential risk factor for EH, while CDKN1B, PDGFRA, and THBS2, regulated by upregulated miRNAs, may act as protective factors. These findings suggest new biomarkers and therapeutic targets for hypertension.